清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Real-world use and outcomes of belimumab in childhood-onset lupus: A single-center retrospective study

贝里穆马布 医学 单中心 回顾性队列研究 内科学 系统性红斑狼疮 儿科 中心(范畴论) 疾病 B细胞激活因子 免疫学 抗体 结晶学 化学 B细胞
作者
Jordan E. Roberts,Cordelia Burn,Rebecca E. Sadun,Emily A. Smitherman,Scott E. Wenderfer,Mary Beth F. Son
出处
期刊:Lupus [SAGE Publishing]
卷期号:32 (9): 1111-1116 被引量:10
标识
DOI:10.1177/09612033231187752
摘要

Studies of real-world effectiveness of belimumab in adults with systemic lupus erythematosus have shown improved disease control and decreased oral glucocorticoid use. However, belimumab use outside of clinical trial settings has not been well studied in childhood-onset systemic lupus erythematosus (cSLE). We aimed to characterize indications for belimumab use and evaluate oral glucocorticoid doses and disease activity scores in the year following belimumab initiation at a single, large pediatric rheumatology center.We included children and young adults with cSLE who received ≥ 1 dose of belimumab. Repeated measures one-way ANOVA was used to compare SLEDAI-2K scores and prednisone-equivalent daily oral glucocorticoid doses at baseline, 6 months, and 12 months after belimumab initiation for those who continued therapy for a year.We identified 21 patients with cSLE who received ≥ 1 dose of belimumab. The median disease duration at belimumab initiation was 30.8 months [IQR 21.0-79.1]. At the time of belimumab initiation, 100% of patients were taking an antimalarial, 81% were on oral glucocorticoids, and 91% were on at least one conventional DMARD. Thirteen patients (62%) continued belimumab for ≥6 months and 11 (52%) for ≥12 months. Among those continuing belimumab for ≥12 months, median [IQR] oral prednisone daily doses in milligrams at baseline, 6 months, and 12 months were 12.5 [7.5-17.5], 9 [6.25-10], and 5 [5-9.5], p = 0.037, and median [IQR] SLEDAI-2K scores at baseline, 6 months, and 12 months were 8 [5.5-10.5], 6 [3.5-10], and 6 [6-8.5], p = 0.548, respectively.In our cohort of pediatric patients with lupus and moderate disease activity treated with belimumab for ≥12 months, daily oral glucocorticoid doses were significantly lower 6 and 12 months after belimumab initiation than baseline. Use in patients with active nephritis was uncommon. Further research is needed in a large, multicenter cohort to determine the real-world effectiveness of belimumab in children and develop guidelines for use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
16秒前
wjx完成签到 ,获得积分10
18秒前
俏皮元珊完成签到 ,获得积分10
20秒前
22秒前
大个应助科研通管家采纳,获得20
29秒前
搜集达人应助科研通管家采纳,获得30
29秒前
elisa828发布了新的文献求助10
34秒前
zijingsy完成签到 ,获得积分10
40秒前
Owen应助像风一样采纳,获得10
41秒前
单小芫完成签到 ,获得积分10
51秒前
52秒前
像风一样完成签到,获得积分20
54秒前
像风一样发布了新的文献求助10
57秒前
1分钟前
深情安青应助念臻采纳,获得10
1分钟前
六六吃了梅完成签到,获得积分20
1分钟前
Jally完成签到 ,获得积分10
1分钟前
王洋完成签到,获得积分10
1分钟前
myq完成签到 ,获得积分10
1分钟前
念臻完成签到,获得积分10
1分钟前
1分钟前
枫威完成签到 ,获得积分10
1分钟前
念臻发布了新的文献求助10
1分钟前
lod完成签到,获得积分10
1分钟前
香锅不要辣完成签到 ,获得积分10
1分钟前
1分钟前
elisa828发布了新的文献求助10
1分钟前
Alex-Song完成签到 ,获得积分0
1分钟前
我是老大应助无限的以亦采纳,获得10
1分钟前
门住完成签到 ,获得积分10
2分钟前
elisa828发布了新的文献求助10
2分钟前
胡国伦完成签到 ,获得积分10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
李东东完成签到 ,获得积分10
2分钟前
自然的含蕾完成签到 ,获得积分10
2分钟前
nuliguan完成签到 ,获得积分10
2分钟前
3分钟前
Alisha完成签到,获得积分10
3分钟前
双子土豆泥完成签到 ,获得积分10
3分钟前
任伟超完成签到,获得积分10
3分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968521
求助须知:如何正确求助?哪些是违规求助? 3513341
关于积分的说明 11167298
捐赠科研通 3248700
什么是DOI,文献DOI怎么找? 1794434
邀请新用户注册赠送积分活动 875030
科研通“疑难数据库(出版商)”最低求助积分说明 804664